Reviews
Summary
Positives
- One patient with long COVID described MDMA as a “blissful experience” that temporarily alleviated their brain fog, allowing them to feel emotions and engage socially for the first time in six months Reddit.
- In another report, a patient reported that after taking MDMA, they “enjoyed a day” for the first time in months, experiencing a slight improvement in cognitive function even days later Reddit.
Negatives
- A patient attempting to manage long COVID symptoms reported that their experience with MDMA was akin to a “bad trip,” causing disorientation, nausea, and other adverse effects Reddit.
Hurdles & Side Effects
- MDMA remains a DEA Schedule I drug, so patients seeking MDMA-assisted therapy in the U.S. are essentially limited to enrolled MAPS clinical trial sites; many trauma-symptom patients are still waiting for FDA approval after the 2024 advisory rejection pushed broader availability further out Nature.
- MAPS’ phase 3 protocol involves twelve sessions, including three drug sessions of six or more hours each with two trained therapists, at a cost of about $11,537 per patient that is not covered by insurance PLOS One.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care